RoPlaVac Overview

  • Year Founded
  • 2010

Year Founded

  • Status
  • Private

  • Latest Deal Type
  • 2ndary - Private

  • Investors
  • 1

RoPlaVac General Information

Description

Developer of a novel vaccination strategy designed to fight malaria. The company specializes in a whole-organism vaccine against malaria that can simultaneously protect against the two major species of malaria-causing parasites, enabling people in malaria-endemic regions with vaccines at affordable prices.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Drug Discovery
Other Industries
Laboratory Services (Healthcare)
Corporate Office
  • Faculdade de Medicina da Universidade de
  • Lisbon, 1649-028
  • Portugal
+351 21 000 0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

RoPlaVac Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Dec-2022 Completed Startup
3. Accelerator/Incubator 24-Apr-2014 Completed Startup
2. Grant 01-Nov-2010 Completed Startup
1. Spin-Off 01-Nov-2010 Completed Startup
To view RoPlaVac’s complete valuation and funding history, request access »

RoPlaVac Executive Team (3)

Name Title Board Seat Contact Info
Antonio Mendes Co-Founder
Maria Mota Co-Founder
Miguel Prudencio Co-Founder
To view RoPlaVac’s complete executive team members history, request access »

RoPlaVac Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Bill & Melinda Gates Foundation Not-For-Profit Venture Capital 000 0000 000000 0
To view RoPlaVac’s complete investors history, request access »

RoPlaVac FAQs

  • When was RoPlaVac founded?

    RoPlaVac was founded in 2010.

  • Who is the founder of RoPlaVac?

    Antonio Mendes, Maria Mota, and Miguel Prudencio are the founders of RoPlaVac.

  • Where is RoPlaVac headquartered?

    RoPlaVac is headquartered in Lisbon, Portugal.

  • What industry is RoPlaVac in?

    RoPlaVac’s primary industry is Drug Discovery.

  • Is RoPlaVac a private or public company?

    RoPlaVac is a Private company.

  • What is RoPlaVac’s current revenue?

    The current revenue for RoPlaVac is 00000.

  • Who are RoPlaVac’s investors?

    Bill & Melinda Gates Foundation has invested in RoPlaVac.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »